(2022). Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR. test, 6(2), -. doi: 10.21608/cvrepj.2022.351488
. "Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR". test, 6, 2, 2022, -. doi: 10.21608/cvrepj.2022.351488
(2022). 'Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR', test, 6(2), pp. -. doi: 10.21608/cvrepj.2022.351488
Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR. test, 2022; 6(2): -. doi: 10.21608/cvrepj.2022.351488

Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR

Cardiovascular Research Prove Journal
Volume 6, Issue 2, December 2022    PDF (97.84 K)
Document Type: Abstracts
DOI: 10.21608/cvrepj.2022.351488
Abstract
Microvascular obstruction (MO) or no-reflow
phenomenon is an established complication of
coronary reperfusion therapy for acute
myocardial infarction. 
Statistics
Article View: 43
PDF Download: 28